Randomized Comparison of Standard vs. Accelerated Corneal Crosslinking for Treatment of Progressive Keratoconus or Ectasia
Who is this study for? Patients with progressive keratoconus or corneal ectasia
What treatments are being studied? Riboflavin
Status: Recruiting
Location: See location...
Intervention Type: Combination product
Study Type: Interventional
Study Phase: Phase 2/Phase 3
SUMMARY
The study objective is to compare accelerated and standard corneal crosslinking for treatment of progressive keratoconus or corneal ectasia.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 10
Healthy Volunteers: f
View:
• Documented keratoconus or ectasia after refractive surgery
Locations
United States
Indiana
Price Vision Group
RECRUITING
Indianapolis
Contact Information
Primary
Marianne Price, PhD
mprice@cornea.org
317-814-2990
Time Frame
Start Date: 2019-04-16
Estimated Completion Date: 2026-07-01
Participants
Target number of participants: 510
Treatments
Active_comparator: Accelerated
Treatment with 0.1% riboflavin eye drops and 9 mW/cm2 UVA light for 10 minutes
Active_comparator: Standard
Treatment with 0.1% riboflavin eye drops and 3 mW/cm2 UVA light for 30 minutes
Related Therapeutic Areas
Sponsors
Leads: Price Vision Group